WCE 2019: Ambulatory Percutaneous Nephrolithotomy in Free - Standing Surgery Center: Outcomes of the First 550 Cases WCE 2019: Investigating the Role of Smaller Tract Percutaneous Nephrolithotomy in ...

December 16, 2025 Is the era within which a TURP was performed associated with differences in reoperation rates, specific surgical side effects, or the requirement for BPH medicat ...

(UroToday.com) In the on-demand poster session of the European Society for Medical Oncology (ESMO) Annual Congress, Dr. Michiel Van der Heijden presented on the design of the SunRISe-1 trial ...

AUA 2025 trial protocol of CORE-008, intravesical cretostimogene grenadenorepvec, non-muscle invasive bladder cancer (NMIBC), RB-E2F alterations.

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

Amy Pearlman discusses penile rehabilitation strategies following prostate cancer treatment. Dr. Pearlman shares her expertise on vacuum pump therapy as a crucial component of penile rehabilitation.

ESMO 2025 final results of PRESTO (AFT-19), phase III trial of combined androgen blockade in patients with high-risk, biochemically relapsed prostate cancer.

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

Read the Full Video Transcript Diane Newman: Welcome to UroToday's Bladder Health Center of Excellence. I am Diane Newman, the center's Editor, and Adjunct Professor of Urology and Surgery at the ...

ASCO GU 2025, Non-Muscle Invasive Bladder Cancer (NMIBC), BCG-Unresponsive Non-Muscle Invasive Bladder Cancer, Durvalumab, Durvalumab plus Intravesical Gemcitabine and Docetaxel, Durvalumab plus ...

Antioxidants for Male Infertility: Therapeutic Scheme and Indications. A Retrospective Single-Center Real-Life Study - Beyond the Abstract ...